Although many studies have focused on CMV and transplant, very few have exploited QuantiFERON CMV, flow cytometric analysis and soluble serum analytes released by activated NK/CD8+ cells to investigate cell subsets that can have a predictive role in the case of CMV infection in patients awaiting LTX. The gene discussed is CD8A; the disease is cytomegalovirus infection.